Instead of testing one gene at a time, our service analyzes the entire coding regions of hundreds of cancer-related genes. This enables us to “tag” every specimen in your inventory with a unique genomic fingerprint.

Benefit: Researchers can instantly query your biobank for specific, hard-to-find genotypes (e.g., “Lung cancer samples with KRAS G12C mutations” or “Breast cancer tissue with PIK3CA amplification“), significantly shortening their cohort selection time.

Routine testing often misses rare variants. our services covers a vast genomic territory, uncovering actionable markers that standard panels overlook.

• Fusion Detection: By sequencing RNA, we identify complex gene fusions (e.g., NTRK, RET, FGFR) that are highly sought after for drug development.
• Copy Number Variations (CNVs): We characterize gene amplifications and deletions, adding another layer of data depth beyond simple point mutations.

For researchers developing immunotherapies (checkpoint inhibitors), knowing the immune profile of a sample is non-negotiable.

• Tumor Mutational Burden (TMB): We provide a precise TMB score (mutations/megabase), allowing researchers to stratify samples into “High-TMB” vs. “Low-TMB” cohorts.

• Microsatellite Instability (MSI): Samples are definitively categorized as MSI-High or MSS, a critical filter for immuno-oncology studies.